Skip to content

The Efficacy of Cognitive Behavioral Therapy for insomnia in combination with Acceptance and Commitment Therapy for the Improvement of Insomnia Severity

The Efficacy of Cognitive Behavioral Therapy for insomnia in combination with Acceptance and Commitment Therapy for the Improvement of Insomnia Severity

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
DRKS
Registry ID
DRKS00020548
Enrollment
84
Registered
2021-06-16
Start date
2021-05-31
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F51.0

Interventions

Group 1: Patients with non-organic insomnia receive a CBT-I group therapy (8 sessions) and additionally in this context sleep education. Group 2: Patients with non-organic insomnia receive a CBT-I gro

Sponsors

Universitätsklinikum Freiburg Klinik für Psychiatrie und Psychotherapie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with insomnia who participated in our DFG-funded study "Emotional regulation in insomnia" and gave their consent to be contacted again for further studies will be contacted again. If they are interested, inclusion and exclusion criteria will be checked. If the planned target sample size won't be reached through our previous DFG-funded study, further participants will be recruited (e.g., through our sleep laboratory). Inclusion criteria: - meeting research diagnostic criteria for insomnia disorder according to DSM 5 (American Psychiatric Association 2013) - age > 18 years - written informed consent

Exclusion criteria

Exclusion criteria: - presence of any other psychiatric diagnosis or any relevant medical/neurological disorder as identified through standard clinical interview – suicidality – abuse or dependency of alcohol, medication or any illegal substance within the past year – sleep disorders except insomnia disorder – intake of sleep medication 2 weeks prior to and during the study treatment – insufficient fluency in German

Design outcomes

Primary

MeasureTime frame
Insomnia Severity Index (ISI) (Bastien et al" 2001, Sleep Med). Self report. Measured 2 weeks before therapy start, at therapy start, immediately after therapy end, 3 months after therapy end, and 6 months after therapy end.

Secondary

MeasureTime frame
Sleep-related parameters: - subjective sleep quality (Pittsburgh Sleep Quality Index, PSQI) - Consensus Sleep Diary - Sleep behaviour (Sleep Hygiene Index, SHI) - Sleep Effort (Glasgow Sleep Effort Scale, GSES) - sleep-related quality of life (Glasgow Sleep Impact Index) - dysfunctional beliefs and attitudes about sleep (DBAS-16) - Pre-Sleep Arousal Scale (PSAS) - Daytime Sleepiness (Epworth Sleepiness Scale, ESS) - Ford Insomnia Response to Stress Test (FORD) Health-related / psychological parameters: - Depression (Beck Depression Inventory, BDI) - Anxiety (State-Trait Anxiety Inventory, STAI) - Psychological flexibility (Acceptance and Action Questionnaire) - Use of emotion regulation strategies (Ecological Momentary Assessment study, EMA): Emotion Regulation Questionnaire (ERQ), Berkley Expressivity Questionnaire (BEQ), Inventory of Cognitive Affect Regulation Strategies (ICARUS), Difficulties in Emotion Regulation Scale (DERS) - perfectionism (Frost Multidimensional Perfectionism Scale, FMPS) Physiological data: - Electrocardiography and actigraphy (ECG and activity sensor, EMA-study) - Epigenetic data (optional) Intervention-related parameters: - negative effects of psychotherapy (Negative Effects Questionnaire, NEQ) - treatment adherence (Treatment Adherence Rating Scale - Therapist Report, TARS-TR) - adverse events - medication status

Countries

Germany

Contacts

Public ContactAnna Johann

UNIVERSITÄTSKLINIKUM FREIBURG Klinik für Psychiatrie und Psychotherapie

schlafstudie@uniklinik-freiburg.de0761/270-69770

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026